Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Skin prick test response to enzyme enolase of the baker's yeast (Saccharomyces cerevisiae) in diagnosis of respiratory allergy.

Marita Nittner-Marszalska, Irena Wójcicka-Kustrzeba, Ewa Bogacka, Janusz Patkowski, Rafał Dobek

Med Sci Monit 2001; 7(1): CR121-124 :: ID: 421176


BACKGROUND: The aim of the study is to prove that Saccharomyces cerevisiaeenolase, the major allergen of the baker's yeast, induces allergic immediate response in patients withinhalant allergy sensitized to Candida albicans extract.
MATERIAL AND METHODS: The study was performedin three groups of patients: I. 20 atopic patients with respiratory allergy sensitized to Candida albicansand inhalant allergens (mite, feather, pollens) II. 30 patients with respiratory allergy, positive skintests to inhalant allergens but negative skin tests to Candida albicans and other fungi; III. 20 nonatopic,healthy individuals. Skin prick test of purified enolase from Saccharomyces cerevisiae (bakers yeast)at concentration 1 and 10 mg/ml was performed in all groups. The results were documented planimetrically.
RESULTS: 95% of patients sensitized to Candida albicans extract showed positive skin reactions to Saccharomycescerevisiae enolase, 10% of patients of group II and none of the patients of the control group had positiveskin responses to enolase. The mean wheal size (mm2) in skin prick test to Candida albicans, Saccharomycescerevisiae enolase at concentration 10 mg/ml was x = 15.17 +/- 11.08, 15.76 +/- 19.67 and at concentration1 mg/ml 10.02 +/- 10.49, respectively.
CONCLUSIONS: 1. Saccharomyces cerevisiae enolase induces an immediateallergic reaction in skin in subjects with respiratory allergy and positive skin prick test results toCandida albicans and other fungi. 2. Enolase can be an important allergenic component of the Candidaalbicans extract.

Keywords: fungal allergy, Saccharomyces cerevisiae enolase, baker's yeast enolase

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Clinical Research  

Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...

Med Sci Monit In Press; DOI: 10.12659/MSM.944222  

Clinical Research  

Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Di...

Med Sci Monit In Press; DOI: 10.12659/MSM.944116  

Database Analysis  

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma

Med Sci Monit In Press; DOI: 10.12659/MSM.943523  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750